TrialSite Staff April 24, 2021
TrialSite has commissioned a project to study the use of ivermectin, favipiravir and other treatments to determine whether the dosages need to be increased based on the circulating powerful variants. The All India Institute of Medical Sciences (AIIMS) recently released Interim Clinic Guidance for Management of COVID-19 based on the massive surge in cases covering patients with mild, moderate and severe cases here.
